🇺🇸 FDA
Patent

US 10105411

Compositions and methods for modulating AT2R activity

granted A61KA61K31/7088A61K38/08

Quick answer

US patent 10105411 (Compositions and methods for modulating AT2R activity) held by NOVOPYXIS INC. expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
NOVOPYXIS INC.
Grant date
Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/7088, A61K38/08, A61K47/10, A61K48/005